These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7726925)

  • 21. National measles and rubella vaccination campaign.
    Wiratunga EB; O'Brien J
    BMJ; 1995 Jun; 310(6993):1532. PubMed ID: 7787613
    [No Abstract]   [Full Text] [Related]  

  • 22. MMR vaccination: new thought.
    Deshmukh V
    Indian Pediatr; 2006 Jun; 43(6):555-6. PubMed ID: 16820670
    [No Abstract]   [Full Text] [Related]  

  • 23. The Measles/Rubella Immunisation Campaign in Greater Glasgow: a success in collaboration.
    Womersley J; Schirn K; Fraser G; Sharkie I; McNulty H; MacNab E; Stewart I
    Health Bull (Edinb); 1996 May; 54(3):223-8. PubMed ID: 8707565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Was a measles epidemic imminent?
    Gay NJ; Miller E
    Commun Dis Rep CDR Rev; 1995 Dec; 5(13):R204-7. PubMed ID: 8556106
    [No Abstract]   [Full Text] [Related]  

  • 25. Sentinel surveillance shows small decline in MMR coverage.
    Commun Dis Rep CDR Wkly; 1998 Sep; 8(36):317, 320. PubMed ID: 9782644
    [No Abstract]   [Full Text] [Related]  

  • 26. Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Nov; 49(46):1048-50, 1059. PubMed ID: 11105768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress towards measles and rubella elimination in Tuscany, Italy: the role of population seroepidemiological profile.
    Bechini A; Boccalini S; Tiscione E; Pesavento G; Mannelli F; Peruzzi M; Rapi S; Mercurio S; Bonanni P
    Eur J Public Health; 2012 Feb; 22(1):133-9. PubMed ID: 20880991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the measles, mumps and rubella vaccination catch-up campaign in England in 2013.
    Simone B; Balasegaram S; Gobin M; Anderson C; Charlett A; Coole L; Maguire H; Nichols T; Rawlings C; Ramsay M; Oliver I
    Vaccine; 2014 Aug; 32(36):4681-8. PubMed ID: 24996125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience.
    Morice A; Carvajal X; León M; Machado V; Badilla X; Reef S; Lievano F; Depetris A; Castillo-Solórzano C
    J Infect Dis; 2003 May; 187 Suppl 1():S158-63. PubMed ID: 12721908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward rubella elimination in Poland: need for supplemental immunization activities, enhanced surveillance, and further integration with measles elimination efforts.
    Zimmerman L; Rogalska J; Wannemuehler KA; Haponiuk M; Kosek A; Pauch E; Plonska E; Veltze D; Czarkowski MP; Buddh N; Reef S; Stefanoff P
    J Infect Dis; 2011 Jul; 204 Suppl 1():S389-95. PubMed ID: 21666189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rubella elimination programme strengthened through measles elimination programme in Catalonia.
    Domínguez A; Torner N; Martínez A; Costa J; Plans P; Ciruela P; Salleras L
    Vaccine; 2006 Feb; 24(9):1433-7. PubMed ID: 16226357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of unfounded vaccine safety concerns on the nationwide measles-rubella immunization campaign, Georgia, 2008.
    Khetsuriani N; Imnadze P; Baidoshvili L; Jabidze L; Tatishili N; Kurtsikashvili G; Lezhava T; Laurent E; Martin R
    Vaccine; 2010 Sep; 28(39):6455-62. PubMed ID: 20674880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles, mumps, and rubella: the need for a change in immunisation policy.
    Walker D; Carter H; Jones IG
    Br Med J (Clin Res Ed); 1986 Jun; 292(6534):1501-2. PubMed ID: 3087495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measles and rubella immunisation campaign. Safety untested.
    Stephenson R
    BMJ; 1994 Oct; 309(6962):1162. PubMed ID: 7987136
    [No Abstract]   [Full Text] [Related]  

  • 35. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance.
    Pistol A; Hennessey K; Pitigoi D; Ion-Nedelcu N; Lupulescu E; Walls L; Bellini W; Strebel P
    J Infect Dis; 2003 May; 187 Suppl 1():S217-22. PubMed ID: 12721916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanded programme on immunization (EPI). Immunization in the English-speaking Caribbean.
    Wkly Epidemiol Rec; 1996 Jul; 71(29):217-23. PubMed ID: 8755341
    [No Abstract]   [Full Text] [Related]  

  • 37. Seroepidemiology of measles, mumps and rubella virus infections in normal children and adults in southern Granada, Spain: response to a vaccination programme.
    Gutiérrez J; Rodríguez M; Huber E; Muñoz A; Piédrola G; Maroto C
    Microbios; 1996; 88(356):143-8. PubMed ID: 9141711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Immunization Programme and Coverage against Measles and Rubella in Spain. Challenges for Achieving their Elimination].
    Limia Sánchez A; Molina Olivas M
    Rev Esp Salud Publica; 2015; 89(4):357-64. PubMed ID: 26580791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elimination of measles and rubella in New Zealand a possibility.
    Essex C
    N Z Med J; 1996 Aug; 109(1027):303. PubMed ID: 8773678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.